AGORACOM SmallCap 60: Awakn LifeSciences In discussions for Phase III AUD Trial To Be Run Within NHS Infrastructure

Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Reply New Message

Prev Message Back To Forum Threaded View Next Message

AGORACOM-NR

Rank: Administrator [?]

Points: 11260 [?]

Votes: 3 Score: 5.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

AGORACOM SmallCap 60: Awakn LifeSciences In discussions for Phase III AUD Trial To Be Run Within NHS Infrastructure

posted on Feb 09, 2022 01:00PM

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply